Salvia miltiorrhiza could be applicable for the treatment of DN by reducing the serum and kidney levels of transforming growth factor β1 (TGF-β1) and the kidney levels of collagen IV, monocytes/macrophages (ED-1), and the receptor for advanced glycation end-products (RAGE) [48]. This evidence concerns the gene TGFB1 and liver dysplastic nodule.